美东时间2020年6月02日,ZNTL股价今开48.7500美元,盘中最高50.8870美元,盘中最低45.8470美元,股价收跌0.05%,跌0.0250点,报49.3250美元

ZNTL简介

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It use its highly efficient drug discovery engine, which it refer to as its Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believe could result in potentially differentiated product profiles. Its discovery engine combines its extensive experience and capabilities across cancer biology and medicinal chemistry.